Stimulus-sensitive polymeric micelles show promise for future targeted drug delivery and chemotherapy
In a recent review published in Pharmaceuticals, researchers documented the various polymeric materials that can be used to synthesize micelles, which can then be used for targeted cancer therapy by tailoring the micelles to respond to stimuli. Study: Exploring the…
Read MoreArtificial sweetener might ease symptoms of rheumatoid arthritis
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info…
Read MoreThe next states that want to try "Medicaid for food" programs
Illustration: Shoshana Gordon/Axios From New Mexico to Maine, a handful of states have pending waiver requests to tap Medicaid funds for food in pilot programs. Why it matters: This signals growing support for "food is medicine" and food-based health interventions…
Read MoreAll-female gynecologic oncology team treating women at Hackensack University Medical Center
When Linda Muller was diagnosed with serous cell endometrial cancer in 2016, she and her husband George turned to the all-female gynecologic oncology team at John Theurer Cancer Center at Hackensack University Medical Center for her care -; a decision…
Read MoreShort night-time sleep linked with nearly doubled risk of clogged leg arteries
Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours. That’s the finding of a study published today in European Heart Journal—Open. “Our study…
Read MoreLebrikizumab Monotherapy Safe, Effective for AD During Induction
Atopic dermatitis (AD) monotherapy with the lebrikizumab, an interleukin-13 inhibitor, was shown to be both effective and safe in the induction periods of the phase 3 ADvocate1 and ADvocate2 trials, researchers reported in the New England Journal of Medicine. The identically designed, 52-week, randomized,…
Read MoreStudy focuses on new approach that delivers a "one-two punch" to help T cells attack solid tumors
A new approach that delivers a "one-two punch" to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania. The findings, published in the…
Read MoreCharacterizing abnormal neural networks in dogs with anxiety
Researchers at Ghent University in Belgium report abnormalities in functional neural networks of dogs diagnosed with anxiety. Led by Yangfeng Xu (Ghent Experimental Psychiatry Lab, GHEP; ORSAMI), and Emma Christiaen (Medical Image and Signal Processing, MEDISIP), the study shows that…
Read MoreVitamin A may reduce pancreatitis risk during ALL treatment
Consuming a diet rich in vitamin A or its analogs may help prevent children and young adults with acute lymphoblastic leukemia (ALL) reduce their risk of developing painful pancreas inflammation during chemotherapy treatment. Details about this potential dietary solution to…
Read MorePopular artificial sweetener may RAISE risk of falling sick
Splenda may hold key to curing type 1 diabetes and arthritis, study suggests Researchers found the sweetener behind Splenda can reduce immune function They hope it could be use as the center of autoimmune disease treatment later READ MORE: WHO…
Read More